Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacokinetic–Pharmacodynamic Relationship: Problems01:24

Pharmacokinetic–Pharmacodynamic Relationship: Problems

The empirical approach to drug therapy optimization relies on correlating pharmacological response with administered dosage. Such an approach can be costly, time-consuming, and often yields poor correlation due to variables like formulation factors and drug elimination characteristics. A more precise approach correlates response with plasma drug concentration or the amount of drug in the body, rather than dosage. This is achieved through pharmacokinetic-pharmacodynamic (PK/PD) modeling, which...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Variance-Consistent Covariate Modeling from Posterior Summaries in Population Pharmacokinetics.

Pharmaceutical research·2026
Same author

Predicting plasma concentration-time profiles of orally disintegrating tablets with delayed absorption under fed conditions without water.

International journal of pharmaceutics·2026
Same author

Platform design of hybrid microphysiological system integrating in vitro and in silico models for reproducing insulin-regulated glucose metabolism.

Scientific reports·2026
Same author

Enhancing Antigen Recognition of Living Cells by Site-Specific VHH Antibody Conjugation.

Chembiochem : a European journal of chemical biology·2025
Same author

Harnessing large language models for structured extraction of cytochrome P450-substance interactions from biomedical texts.

International journal of pharmaceutics·2025
Same author

Pharmacokinetic Simulation of Optimal Lopinavir and Ritonavir Dose Combination for COVID-19: Boosting Lopinavir With Ritonavir.

In vivo (Athens, Greece)·2025

Related Experiment Video

Updated: Jul 19, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

Quantitative structure/activity relationship modelling of pharmacokinetic properties using genetic algorithm-combined

Fumiyoshi Yamashita1, Shin-Ichi Fujiwara, Suchada Wanchana

  • 1Department of Drug Delivery Research, Graduate School of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto, 606-8501, Japan.

Journal of Drug Targeting
|October 26, 2006
PubMed
Summary

Quantitative structure-activity relationship (QSAR) models predict ADME properties using molecular structures. Genetic algorithm-partial least squares (GA-PLS) effectively identified key descriptors for diverse compounds.

More Related Videos

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

Related Experiment Videos

Last Updated: Jul 19, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
10:29

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors

Published on: May 9, 2025

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
14:34

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English

Published on: April 3, 2026

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

Area of Science:

  • Computational chemistry and cheminformatics
  • Drug discovery and development
  • Pharmacokinetics and toxicology

Background:

  • Quantitative structure-activity relationship (QSAR) studies are crucial for understanding how molecular structure influences Absorption, Distribution, Metabolism, and Excretion (ADME) properties.
  • Developing robust QSAR models requires diverse chemical structures to ensure broad applicability.
  • Accurate prediction of ADME properties is essential for efficient drug design and reducing late-stage failures.

Purpose of the Study:

  • To apply the genetic algorithm-partial least squares (GA-PLS) method for QSAR modeling of various ADME properties.
  • To demonstrate the effectiveness of automated descriptor selection using genetic algorithms.
  • To establish QSAR models that explain ADME properties using simple 2D molecular descriptors.

Main Methods:

  • Utilized the genetic algorithm-partial least squares (GA-PLS) approach for QSAR model development.
  • Employed genetic algorithms for automatic selection of optimal molecular descriptors.
  • Focused on descriptors derived from 2-dimensional chemical structures.

Main Results:

  • The GA-PLS method successfully modeled and explained various ADME properties.
  • Automated descriptor selection by genetic algorithms led to simplified and effective QSAR models.
  • The developed models demonstrated good explanatory power for diverse chemical compounds.

Conclusions:

  • The GA-PLS method is a powerful tool for developing QSAR models of ADME properties.
  • Simple 2D molecular descriptors, when selected appropriately, can effectively predict complex ADME behaviors.
  • This approach facilitates a deeper understanding of structure-ADME relationships in drug discovery.